Black Rock Inc. Nuvalent, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Nuvalent, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,023,626 shares of NUVL stock, worth $254 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,023,626

Previous 2,708,458 11.64%

Holding current value

$254 Million

Previous $203 Million 12.78%

% of portfolio

0.01%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$62.76 - $81.61 $19.8 Million - $25.7 Million	315,168 Added 11.64%	3,023,626 $229 Million
Q1 2024 May 10, 2024	SELL	$72.35 - $88.99 $921,521 - $1.13 Million	-12,737 Reduced 0.47%	2,708,458 $203 Million
Q4 2023 Feb 13, 2024	BUY	$42.42 - $80.28 $12.4 Million - $23.4 Million	291,216 Added 11.98%	2,721,195 $200 Million
Q3 2023 Nov 13, 2023	BUY	$39.12 - $49.85 $1.3 Million - $1.65 Million	33,115 Added 1.38%	2,429,979 $112 Million
Q2 2023 Aug 11, 2023	BUY	$23.58 - $44.68 $4.74 Million - $8.98 Million	200,966 Added 9.15%	2,396,864 $101 Million
Q1 2023 May 12, 2023	BUY	$25.42 - $33.52 $487,021 - $642,209	19,159 Added 0.88%	2,195,898 $57.3 Million
Q4 2022 Feb 13, 2023	BUY	$18.46 - $36.37 $14.1 Million - $27.8 Million	765,185 Added 54.21%	2,176,739 $64.8 Million
Q3 2022 Nov 14, 2022	BUY	$13.55 - $19.92 $1.4 Million - $2.06 Million	103,548 Added 7.92%	1,411,554 $27.4 Million
Q2 2022 Aug 12, 2022	BUY	$7.4 - $15.07 $374,018 - $761,683	50,543 Added 4.02%	1,308,006 $17.7 Million
Q1 2022 May 12, 2022	BUY	$11.65 - $19.57 $3.4 Million - $5.71 Million	291,821 Added 30.22%	1,257,463 $17.5 Million
Q4 2021 Feb 10, 2022	BUY	$18.01 - $30.1 $5.63 Million - $9.41 Million	312,512 Added 47.85%	965,642 $18.4 Million
Q3 2021 Nov 09, 2021	BUY	$18.25 - $38.35 $11.9 Million - $25 Million	653,130 New	653,130 $14.7 Million

Others Institutions Holding NUVL

# of Institutions

209

Shares Held

59.5M

Call Options Held

450K

Put Options Held

619K

View Full List

About Nuvalent, Inc.

Ticker NUVL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,977,800
Market Cap $3.6B
Description
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...

More about NUVL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account